These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 19005479)
21. Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy? Falini B; Gionfriddo I; Cecchetti F; Ballanti S; Pettirossi V; Martelli MP Blood Rev; 2011 Nov; 25(6):247-54. PubMed ID: 21724308 [TBL] [Abstract][Full Text] [Related]
22. Deguelin, a selective silencer of the NPM1 mutant, potentiates apoptosis and induces differentiation in AML cells carrying the NPM1 mutation. Yi S; Wen L; He J; Wang Y; Zhao F; Zhao J; Zhao Z; Cui G; Chen Y Ann Hematol; 2015 Feb; 94(2):201-10. PubMed ID: 25242579 [TBL] [Abstract][Full Text] [Related]
23. Myeloid leukemia-associated nucleophosmin mutants perturb p53-dependent and independent activities of the Arf tumor suppressor protein. den Besten W; Kuo ML; Williams RT; Sherr CJ Cell Cycle; 2005 Nov; 4(11):1593-8. PubMed ID: 16205118 [TBL] [Abstract][Full Text] [Related]
24. Delineation of the domains required for physical and functional interaction of p14ARF with human topoisomerase I. Ayrault O; Karayan L; Riou JF; Larsen CJ; Séité P Oncogene; 2003 Apr; 22(13):1945-54. PubMed ID: 12673200 [TBL] [Abstract][Full Text] [Related]
25. Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice. Falini B; Martelli MP; Mecucci C; Liso A; Bolli N; Bigerna B; Pucciarini A; Pileri S; Meloni G; Martelli MF; Haferlach T; Schnittger S Haematologica; 2008 May; 93(5):775-9. PubMed ID: 18367491 [TBL] [Abstract][Full Text] [Related]
27. Cytoplasmic expression of nucleophosmin accurately predicts mutation in the nucleophosmin gene in patients with acute myeloid leukemia and normal karyotype. Luo J; Qi C; Xu W; Kamel-Reid S; Brandwein J; Chang H Am J Clin Pathol; 2010 Jan; 133(1):34-40. PubMed ID: 20023256 [TBL] [Abstract][Full Text] [Related]
28. Immunolocalization of human p14(ARF) to the granular component of the interphase nucleolus. Lindström MS; Klangby U; Inoue R; Pisa P; Wiman KG; Asker CE Exp Cell Res; 2000 May; 256(2):400-10. PubMed ID: 10772813 [TBL] [Abstract][Full Text] [Related]
29. Two novel NPM1 mutations in a therapy-responder AML patient. Pianta A; Fabbro D; Damiani D; Tiribelli M; Fanin R; Franzoni A; Romanello M; Tell G; Di Loreto C; Damante G Hematol Oncol; 2010 Sep; 28(3):151-5. PubMed ID: 19593743 [TBL] [Abstract][Full Text] [Related]
30. ARF suppresses tumor angiogenesis through translational control of VEGFA mRNA. Kawagishi H; Nakamura H; Maruyama M; Mizutani S; Sugimoto K; Takagi M; Sugimoto M Cancer Res; 2010 Jun; 70(11):4749-58. PubMed ID: 20501856 [TBL] [Abstract][Full Text] [Related]
31. Mutations of NPM1 gene in de novo acute myeloid leukaemia: determination of incidence, distribution pattern and identification of two novel mutations in Indian population. Ahmad F; Mandava S; Das BR Hematol Oncol; 2009 Jun; 27(2):90-7. PubMed ID: 19365794 [TBL] [Abstract][Full Text] [Related]
32. NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia. Falini B; Mecucci C; Saglio G; Lo Coco F; Diverio D; Brown P; Pane F; Mancini M; Martelli MP; Pileri S; Haferlach T; Haferlach C; Schnittger S Haematologica; 2008 Mar; 93(3):439-42. PubMed ID: 18268276 [TBL] [Abstract][Full Text] [Related]
33. A novel leukemic route of mutant NPM1 through nuclear import of the overexpressed long noncoding RNA LONA. Gourvest M; De Clara E; Wu HC; Touriol C; Meggetto F; De Thé H; Pyronnet S; Brousset P; Bousquet M Leukemia; 2021 Oct; 35(10):2784-2798. PubMed ID: 34131282 [TBL] [Abstract][Full Text] [Related]
34. In human genome, generation of a nuclear export signal through duplication appears unique to nucleophosmin (NPM1) mutations and is restricted to AML. Liso A; Bogliolo A; Freschi V; Martelli MP; Pileri SA; Santodirocco M; Bolli N; Martelli MF; Falini B Leukemia; 2008 Jun; 22(6):1285-9. PubMed ID: 18059485 [No Abstract] [Full Text] [Related]
35. The leukemia-associated cytoplasmic nucleophosmin mutant is an oncogene with paradoxical functions: Arf inactivation and induction of cellular senescence. Cheng K; Grisendi S; Clohessy JG; Majid S; Bernardi R; Sportoletti P; Pandolfi PP Oncogene; 2007 Nov; 26(53):7391-400. PubMed ID: 17546053 [TBL] [Abstract][Full Text] [Related]